Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Selects ZS to Support Global Commercial Analytics

[PR Newswire] – EVANSTON, Ill., Sept. 21, 2015 /PRNewswire/ — ZS – a global leader in sales and marketing consulting, outsourcing, technology and software – has been selected by global biopharmaceutical company Bristol-Myers . . . → Read More: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Selects ZS to Support Global Commercial Analytics Similar Articles: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – R-PHARM Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial Operations Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb and The Leukemia & Lymphoma Society Announce Charitable Donation to Support Critical Routine Testing and Awareness for Chronic Myeloid Leukemia Patients Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S.